Title : EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer.

Pub. Date : 2018 Feb

PMID : 29413056






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our results suggested that YM155, an ILF3 inhibitor, has the potential for utilization in cancer therapy against EGFR-positive lung cancers. YM 155 epidermal growth factor receptor Homo sapiens